Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Forxiga

Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10

HOS-125371 · Präparat HOS-096051

In the DAPA-HF study, no patient reported serious adverse events of genital infections in the dapagliflozin group and one in the placebo group. There were 7 (0.3%) patients with adverse events leading to discontinuations due to genital infections in the dapagliflozin group and none in the placebo group. In the DELIVER study, one (< 0.1%) patient in each treatment group reported a serious adverse event of genital infections. There were 3 (0.1%) patients with adverse events leading to discontinuations due to genital infection in the dapagliflozin group and none in the placebo group.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.